Key Insights
The Middle East and Africa Diabetes Care Devices market is experiencing robust growth, projected to reach \$2.43 billion in 2025 and expanding at a CAGR of 4.12% from 2025 to 2033. This expansion is driven by several factors, including the rising prevalence of diabetes, increasing awareness of effective diabetes management, and growing adoption of advanced technologies like continuous glucose monitoring (CGM) systems. The increasing urbanization and improving healthcare infrastructure across the region also contribute to market growth. The segment encompassing continuous glucose monitoring (CGM) devices and insulin pumps is expected to witness the most significant growth due to their convenience and enhanced precision in managing blood glucose levels. However, high costs associated with advanced devices, particularly CGMs and insulin pumps, coupled with limited healthcare access in certain regions, present significant challenges to market penetration. Furthermore, variations in regulatory frameworks across different countries in the region can also impact market expansion. The growth is also fueled by initiatives to improve diabetes awareness and management programs, including governmental support for disease prevention and management programs and increased investment in diabetes research. Specific countries like South Africa, Kenya, and Egypt, with their relatively high diabetic populations and improving healthcare sectors, will likely drive a significant portion of this market growth.
Growth will be fueled by increasing adoption of technologically advanced devices, improved healthcare infrastructure in key regions, and initiatives aimed at raising awareness and improving diabetes management. However, the market faces restraints such as the high cost of advanced devices, the prevalence of affordability challenges, and the need for improved healthcare access in several areas. Companies are focusing on developing cost-effective solutions and expanding access through strategic partnerships and collaborations with healthcare providers. The competitive landscape is marked by the presence of both established multinational corporations and smaller, regional players, leading to intense competition and innovation within the diabetes care devices market. The focus on innovation and technological advancements in areas such as minimally invasive insulin delivery methods and advanced data analytics is likely to shape the future trajectory of this market.
Middle East & Africa Diabetes Care Devices Market: A Comprehensive Report (2019-2033)
This insightful report provides a detailed analysis of the burgeoning Middle East & Africa Diabetes Care Devices Market, offering a comprehensive overview of market dynamics, growth drivers, challenges, and future opportunities from 2019 to 2033. The study encompasses a thorough examination of various segments, including lancets, continuous glucose monitoring (CGM) devices, insulin pumps, insulin infusion sets, insulin syringes, insulin pens, jet injectors, and self-monitoring blood glucose (SMBG) devices. With a base year of 2025 and a forecast period extending to 2033, this report is an indispensable resource for stakeholders seeking to navigate this rapidly evolving market. The report incorporates data on market size (in Millions), competitive landscape analysis, and key industry developments.
Middle East And Africa Diabetes Care Devices Market Market Composition & Trends
The Middle East & Africa Diabetes Care Devices Market exhibits a moderately concentrated landscape, with key players like Roche Diabetes Care, Abbott Diabetes Care, and Medtronic PLC holding significant market share. However, the market is witnessing increased competition from smaller, innovative companies focusing on advanced technologies like CGM and insulin pump systems. The market's growth is propelled by factors such as rising diabetes prevalence, increasing healthcare expenditure, and growing awareness regarding diabetes management. Regulatory approvals and initiatives aimed at improving diabetes care further contribute to market expansion. The market is also witnessing a rising trend of mergers and acquisitions (M&A), with deal values exceeding xx Million in recent years. For instance, the strategic partnership between Becton, Dickinson, and Company and Biocorp illustrates a trend of technological integration and data-driven insights in diabetes management.
- Market Concentration: Moderately concentrated, with top players holding xx% market share.
- Innovation Catalysts: Advancements in CGM, insulin pump technology, and data analytics drive innovation.
- Regulatory Landscape: Stringent regulatory approvals are essential for market entry, but supportive government initiatives are fostering growth.
- Substitute Products: Limited substitute products exist, but alternative therapies and lifestyle modifications impact market growth.
- End-User Profiles: Primarily encompasses hospitals, clinics, and individual patients, with a growing focus on home healthcare solutions.
- M&A Activities: Several significant M&A activities were observed with a total deal value of approximately xx Million in the past five years.
Middle East And Africa Diabetes Care Devices Market Industry Evolution
The Middle East & Africa Diabetes Care Devices Market has witnessed significant growth over the historical period (2019-2024), expanding at a CAGR of xx%. This growth is primarily fueled by the increasing prevalence of diabetes and improvements in the diagnostic and therapeutic capabilities of devices. Technological advancements, particularly in CGM and insulin pump technology, have made diabetes management easier and more effective, contributing substantially to the market growth. Furthermore, there is a significant shift in consumer demand towards innovative, user-friendly, and connected devices providing more comprehensive data and support. The market is also seeing a trend toward personalized medicine, with devices tailored to specific patient needs and preferences. The forecast period (2025-2033) is expected to witness a CAGR of xx%, propelled by factors such as enhanced healthcare infrastructure, rising disposable incomes, and growing awareness campaigns.
Leading Regions, Countries, or Segments in Middle East And Africa Diabetes Care Devices Market
The Middle East and Africa diabetes care devices market is segmented by device type, with significant variations in growth across regions and segments.
Dominant Regions/Countries: South Africa, Egypt, and the UAE are projected to be leading markets within the region due to factors like high prevalence of diabetes, strong healthcare infrastructure, and government initiatives supporting diabetes management.
Dominant Segments:
- CGM Devices: Experiencing rapid growth driven by improved accuracy, ease of use, and continuous monitoring capabilities. Key drivers include increasing patient preference for convenience and improved glycemic control, along with rising healthcare expenditure.
- Insulin Pumps: Growing adoption due to enhanced convenience and effectiveness compared to traditional insulin injection methods. Government support and rising disposable incomes are bolstering adoption.
- SMBG Devices: While relatively mature, this segment still holds significant market share, driven by affordability and ease of use. The segment is also seeing innovation in the form of connected devices.
Key Drivers (Bullet Points):
- Increased investment in healthcare infrastructure.
- Government initiatives to improve diabetes care and control.
- Rising prevalence of type 1 and type 2 diabetes.
- Growing awareness among patients about improved diabetes management.
Middle East And Africa Diabetes Care Devices Market Product Innovations
The market is characterized by continuous innovation, with new devices and technologies improving accuracy, ease of use, and patient outcomes. Recent innovations include smaller, more discreet CGM sensors, improved insulin pump designs with advanced features like bolus calculators and remote monitoring capabilities, and the emergence of non-invasive glucose sensors. These innovations are enhancing patient convenience and improving adherence to treatment regimens, ultimately contributing to better diabetes management and reduced long-term complications.
Propelling Factors for Middle East And Africa Diabetes Care Devices Market Growth
Several factors are driving market growth: the increasing prevalence of diabetes, particularly in urban areas; rising disposable incomes; improving healthcare infrastructure; government initiatives promoting diabetes awareness and management; and technological advancements leading to more user-friendly and effective devices. Examples include the increasing adoption of CGM systems and the expansion of telemedicine services for diabetes management.
Obstacles in the Middle East And Africa Diabetes Care Devices Market Market
The market faces several challenges, including the high cost of diabetes care devices, limiting access for many patients; inconsistent healthcare infrastructure across the region; and limited awareness of advanced technologies among healthcare professionals and patients. Furthermore, supply chain disruptions can impact device availability, and competition from generic manufacturers can exert downward pressure on prices. These factors contribute to complexities in market penetration and profitability for various industry players.
Future Opportunities in Middle East And Africa Diabetes Care Devices Market
Future opportunities lie in expanding market access through affordability programs and improved distribution networks; introducing innovative technologies such as artificial pancreas systems and closed-loop CGM systems; and focusing on patient education and telehealth solutions. Growth is also expected through partnerships with local healthcare providers and increased government support for diabetes care initiatives. Furthermore, addressing the unique needs of specific populations, such as children and the elderly, presents lucrative opportunities for specialized product development and targeted marketing.
Major Players in the Middle East And Africa Diabetes Care Devices Market Ecosystem
- Rossmax
- Roche Diabetes Care
- Sanofi
- Eli Lilly
- Abbott Diabetes Care
- Dexcom Inc
- Insulet Corporation
- Medtronic PLC
- Agamatrix Inc
- Lifescan
- Bionime Corporation
- Novo Nordisk A/S
- Ascensia Diabetes Care
Key Developments in Middle East And Africa Diabetes Care Devices Market Industry
- August 2023: Nemaura Medical receives SFDA approval for its sugarBEAT non-invasive wearable glucose sensor, indicating strong regulatory support and market entry in the Middle East. The significant provisional purchase order of 1.7 million sensors and 17,000 devices further highlights market potential.
- October 2022: Becton, Dickinson, and Company and Biocorp's collaboration on connected injection technology aims to improve drug adherence, suggesting a shift towards data-driven diabetes management strategies.
Strategic Middle East And Africa Diabetes Care Devices Market Market Forecast
The Middle East & Africa Diabetes Care Devices Market is poised for significant growth, driven by rising diabetes prevalence, technological advancements, and increased healthcare spending. Future opportunities are abundant, particularly in the areas of advanced CGM, insulin pump technologies, and data-driven diabetes management solutions. The market's expansion will be further fueled by increased government initiatives and rising awareness campaigns promoting proactive diabetes care. This positive outlook presents a compelling investment case for companies operating within this dynamic sector.
Middle East And Africa Diabetes Care Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pumps
- 2.1.1. Insulin Pump Monitor
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Insulin Infusion Sets
- 2.2. Insulin Syringes
- 2.3. Insulin Disposable Pens
- 2.4. Insulin Cartridges in Reusable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pumps
-
3. Geography
- 3.1. Saudi Arabia
- 3.2. Iran
- 3.3. Egypt
- 3.4. Oman
- 3.5. South Africa
- 3.6. Rest of Middle East and Africa
Middle East And Africa Diabetes Care Devices Market Segmentation By Geography
- 1. Saudi Arabia
- 2. Iran
- 3. Egypt
- 4. Oman
- 5. South Africa
- 6. Rest of Middle East and Africa
Middle East And Africa Diabetes Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 4.12% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Digital Dentistry
- 3.4. Market Trends
- 3.4.1. Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pumps
- 5.2.1.1. Insulin Pump Monitor
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Insulin Infusion Sets
- 5.2.2. Insulin Syringes
- 5.2.3. Insulin Disposable Pens
- 5.2.4. Insulin Cartridges in Reusable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pumps
- 5.3. Market Analysis, Insights and Forecast - by Geography
- 5.3.1. Saudi Arabia
- 5.3.2. Iran
- 5.3.3. Egypt
- 5.3.4. Oman
- 5.3.5. South Africa
- 5.3.6. Rest of Middle East and Africa
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. Saudi Arabia
- 5.4.2. Iran
- 5.4.3. Egypt
- 5.4.4. Oman
- 5.4.5. South Africa
- 5.4.6. Rest of Middle East and Africa
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. Saudi Arabia Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring Devices
- 6.1.2.1. Sensors
- 6.1.2.2. Durables (Receivers and Transmitters)
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pumps
- 6.2.1.1. Insulin Pump Monitor
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Insulin Infusion Sets
- 6.2.2. Insulin Syringes
- 6.2.3. Insulin Disposable Pens
- 6.2.4. Insulin Cartridges in Reusable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pumps
- 6.3. Market Analysis, Insights and Forecast - by Geography
- 6.3.1. Saudi Arabia
- 6.3.2. Iran
- 6.3.3. Egypt
- 6.3.4. Oman
- 6.3.5. South Africa
- 6.3.6. Rest of Middle East and Africa
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. Iran Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring Devices
- 7.1.2.1. Sensors
- 7.1.2.2. Durables (Receivers and Transmitters)
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pumps
- 7.2.1.1. Insulin Pump Monitor
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Insulin Infusion Sets
- 7.2.2. Insulin Syringes
- 7.2.3. Insulin Disposable Pens
- 7.2.4. Insulin Cartridges in Reusable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pumps
- 7.3. Market Analysis, Insights and Forecast - by Geography
- 7.3.1. Saudi Arabia
- 7.3.2. Iran
- 7.3.3. Egypt
- 7.3.4. Oman
- 7.3.5. South Africa
- 7.3.6. Rest of Middle East and Africa
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Egypt Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring Devices
- 8.1.2.1. Sensors
- 8.1.2.2. Durables (Receivers and Transmitters)
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pumps
- 8.2.1.1. Insulin Pump Monitor
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Insulin Infusion Sets
- 8.2.2. Insulin Syringes
- 8.2.3. Insulin Disposable Pens
- 8.2.4. Insulin Cartridges in Reusable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pumps
- 8.3. Market Analysis, Insights and Forecast - by Geography
- 8.3.1. Saudi Arabia
- 8.3.2. Iran
- 8.3.3. Egypt
- 8.3.4. Oman
- 8.3.5. South Africa
- 8.3.6. Rest of Middle East and Africa
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Oman Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring Devices
- 9.1.2.1. Sensors
- 9.1.2.2. Durables (Receivers and Transmitters)
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pumps
- 9.2.1.1. Insulin Pump Monitor
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Insulin Infusion Sets
- 9.2.2. Insulin Syringes
- 9.2.3. Insulin Disposable Pens
- 9.2.4. Insulin Cartridges in Reusable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pumps
- 9.3. Market Analysis, Insights and Forecast - by Geography
- 9.3.1. Saudi Arabia
- 9.3.2. Iran
- 9.3.3. Egypt
- 9.3.4. Oman
- 9.3.5. South Africa
- 9.3.6. Rest of Middle East and Africa
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. South Africa Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring Devices
- 10.1.2.1. Sensors
- 10.1.2.2. Durables (Receivers and Transmitters)
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pumps
- 10.2.1.1. Insulin Pump Monitor
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Insulin Infusion Sets
- 10.2.2. Insulin Syringes
- 10.2.3. Insulin Disposable Pens
- 10.2.4. Insulin Cartridges in Reusable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pumps
- 10.3. Market Analysis, Insights and Forecast - by Geography
- 10.3.1. Saudi Arabia
- 10.3.2. Iran
- 10.3.3. Egypt
- 10.3.4. Oman
- 10.3.5. South Africa
- 10.3.6. Rest of Middle East and Africa
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Rest of Middle East and Africa Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.1.1.1. Glucometer Devices
- 11.1.1.2. Blood Glucose Test Strips
- 11.1.1.3. Lancets
- 11.1.2. Continuous Glucose Monitoring Devices
- 11.1.2.1. Sensors
- 11.1.2.2. Durables (Receivers and Transmitters)
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.2. Market Analysis, Insights and Forecast - by Management Devices
- 11.2.1. Insulin Pumps
- 11.2.1.1. Insulin Pump Monitor
- 11.2.1.2. Insulin Pump Reservoir
- 11.2.1.3. Insulin Infusion Sets
- 11.2.2. Insulin Syringes
- 11.2.3. Insulin Disposable Pens
- 11.2.4. Insulin Cartridges in Reusable Pens
- 11.2.5. Jet Injectors
- 11.2.1. Insulin Pumps
- 11.3. Market Analysis, Insights and Forecast - by Geography
- 11.3.1. Saudi Arabia
- 11.3.2. Iran
- 11.3.3. Egypt
- 11.3.4. Oman
- 11.3.5. South Africa
- 11.3.6. Rest of Middle East and Africa
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12. South Africa Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 13. Sudan Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. Uganda Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. Tanzania Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. Kenya Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 17. Rest of Africa Middle East And Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 18. Competitive Analysis
- 18.1. Market Share Analysis 2024
- 18.2. Company Profiles
- 18.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSI
- 18.2.1.1. Overview
- 18.2.1.2. Products
- 18.2.1.3. SWOT Analysis
- 18.2.1.4. Recent Developments
- 18.2.1.5. Financials (Based on Availability)
- 18.2.2 Roche Diabetes Care
- 18.2.2.1. Overview
- 18.2.2.2. Products
- 18.2.2.3. SWOT Analysis
- 18.2.2.4. Recent Developments
- 18.2.2.5. Financials (Based on Availability)
- 18.2.3 Sanofi
- 18.2.3.1. Overview
- 18.2.3.2. Products
- 18.2.3.3. SWOT Analysis
- 18.2.3.4. Recent Developments
- 18.2.3.5. Financials (Based on Availability)
- 18.2.4 Eli Lilly
- 18.2.4.1. Overview
- 18.2.4.2. Products
- 18.2.4.3. SWOT Analysis
- 18.2.4.4. Recent Developments
- 18.2.4.5. Financials (Based on Availability)
- 18.2.5 Abbott Diabetes Care
- 18.2.5.1. Overview
- 18.2.5.2. Products
- 18.2.5.3. SWOT Analysis
- 18.2.5.4. Recent Developments
- 18.2.5.5. Financials (Based on Availability)
- 18.2.6 Dexcom Inc
- 18.2.6.1. Overview
- 18.2.6.2. Products
- 18.2.6.3. SWOT Analysis
- 18.2.6.4. Recent Developments
- 18.2.6.5. Financials (Based on Availability)
- 18.2.7 Insulet Corporation
- 18.2.7.1. Overview
- 18.2.7.2. Products
- 18.2.7.3. SWOT Analysis
- 18.2.7.4. Recent Developments
- 18.2.7.5. Financials (Based on Availability)
- 18.2.8 Medtronic PLC
- 18.2.8.1. Overview
- 18.2.8.2. Products
- 18.2.8.3. SWOT Analysis
- 18.2.8.4. Recent Developments
- 18.2.8.5. Financials (Based on Availability)
- 18.2.9 Agamatrix Inc
- 18.2.9.1. Overview
- 18.2.9.2. Products
- 18.2.9.3. SWOT Analysis
- 18.2.9.4. Recent Developments
- 18.2.9.5. Financials (Based on Availability)
- 18.2.10 Lifescan
- 18.2.10.1. Overview
- 18.2.10.2. Products
- 18.2.10.3. SWOT Analysis
- 18.2.10.4. Recent Developments
- 18.2.10.5. Financials (Based on Availability)
- 18.2.11 Bionime Corporation
- 18.2.11.1. Overview
- 18.2.11.2. Products
- 18.2.11.3. SWOT Analysis
- 18.2.11.4. Recent Developments
- 18.2.11.5. Financials (Based on Availability)
- 18.2.12 Novo Nordisk A/S
- 18.2.12.1. Overview
- 18.2.12.2. Products
- 18.2.12.3. SWOT Analysis
- 18.2.12.4. Recent Developments
- 18.2.12.5. Financials (Based on Availability)
- 18.2.13 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 18.2.13.1. Overview
- 18.2.13.2. Products
- 18.2.13.3. SWOT Analysis
- 18.2.13.4. Recent Developments
- 18.2.13.5. Financials (Based on Availability)
- 18.2.14 Ascensia Diabetes Care
- 18.2.14.1. Overview
- 18.2.14.2. Products
- 18.2.14.3. SWOT Analysis
- 18.2.14.4. Recent Developments
- 18.2.14.5. Financials (Based on Availability)
- 18.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSI
List of Figures
- Figure 1: Middle East And Africa Diabetes Care Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Middle East And Africa Diabetes Care Devices Market Share (%) by Company 2024
List of Tables
- Table 1: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 5: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 7: South Africa Middle East And Africa Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Sudan Middle East And Africa Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Uganda Middle East And Africa Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Tanzania Middle East And Africa Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Kenya Middle East And Africa Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Africa Middle East And Africa Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 14: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 15: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 16: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 17: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 18: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 19: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 20: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 21: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 22: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 23: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 24: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 25: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 26: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 27: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 28: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 29: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 30: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 31: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 32: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 33: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 34: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 35: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 36: Middle East And Africa Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Middle East And Africa Diabetes Care Devices Market?
The projected CAGR is approximately 4.12%.
2. Which companies are prominent players in the Middle East And Africa Diabetes Care Devices Market?
Key companies in the market include Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSI, Roche Diabetes Care, Sanofi, Eli Lilly, Abbott Diabetes Care, Dexcom Inc, Insulet Corporation, Medtronic PLC, Agamatrix Inc, Lifescan, Bionime Corporation, Novo Nordisk A/S, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Ascensia Diabetes Care.
3. What are the main segments of the Middle East And Africa Diabetes Care Devices Market?
The market segments include Monitoring Devices, Management Devices, Geography.
4. Can you provide details about the market size?
The market size is estimated to be USD 2.43 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income.
6. What are the notable trends driving market growth?
Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost Associated with the Digital Dentistry.
8. Can you provide examples of recent developments in the market?
August 2023: Nemaura Medical has received approval from the Saudi Food and Drug Authority (SFDA) for its non-invasive wearable glucose sensor, sugarBEAT. This approval follows more than a year of partnership with the SFDA through the company’s licensee in the Middle East, TPMENA, from which Nemaura previously received a provisional purchase order for 1.7 million sensors and 17,000 devices.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Middle East And Africa Diabetes Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Middle East And Africa Diabetes Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Middle East And Africa Diabetes Care Devices Market?
To stay informed about further developments, trends, and reports in the Middle East And Africa Diabetes Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
